Evidence map›Paper›PMID 41647071›Full record

ArticleRegenerative engineering and translational medicine2025

Silk Fibroin Particle-Laden Sponges as a Multiphase Controlled Release Platform.

Marisa O Pacheco, Cathrine A Beshay, Whitney L Stoppel

Abstract read
In one paragraph

Article in Regenerative engineering and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marisa O PachecoChemical Engineering, University of Florida, Gainesville FL.ORCID 0000-0002-4669-5050
Cathrine A BeshayJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville FL.
Whitney L StoppelChemical Engineering, University of Florida, Gainesville FL.ORCID 0000-0001-7467-1737

Funding

Leveraging biodiversity and utilizing genetic engineering to expand the structure and function of silk fibroin biopolymers for biomedical applicationsR35GM147041 · NIGMS · UNIVERSITY OF FLORIDA · PI Whitney L Stoppel · 2022 to 2026
$1.9M
NIGMS NIH HHS R35 GM147041
6 · The paper itself

Abstract

Purpose: Silk fibroin-based biomaterials have shown utility across regenerative medicine applications due to their ability to provide robust mechanical support and deliver bioactive cargo. To achieve diverse functions, fibroin can be fabricated into material formats with varied morphology including sponge-like scaffolds and microparticles. This study investigates the potential of a dual-component silk fibroin system (particle-laden sponges) to enable two-phase controlled release and assesses the impact of cytokine release on RAW 264.7 polarization. Methods: Silk fibroin microparticles (SFMPs) were prepared through phase separation from PVA before being combined with aqueous fibroin polymer solution at desired mass ratios. This solution was frozen and lyophilized to form a particle-laden sponge. The sponge was then water annealed to induce crystallinity at a set temperature. Sponge morphology was assessed with SEM and crystallinity was assessed with FTIR. Results: Both formulation and temperature during water annealing were found to impact morphology and total crystalline content. Degradation studies showed disruption of the sponge like structures prior to SFMP degradation, indicating a potential for a multiphase controlled release platform. RAW 264.7 cells showed a polarization switch from M1 to M2 in line with hypothesized rates of release from the particle-laden sponge. Conclusion: This study demonstrated the tunability of a dual-component silk fibroin sponge, while also establishing its potential as a multiphase controlled release platform to modulate immune interactions in future

Indexed as

biomaterialsbiopolymerscontrolled releasesilk fibroin

Identifiers

PMID41647071
PMCPMC12872209

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.